Clinical trials
Hyperlipidemias trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
843 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 8 |
| 2001 | 5 |
| 2002 | 6 |
| 2003 | 11 |
| 2004 | 34 |
| 2005 | 37 |
| 2006 | 32 |
| 2007 | 43 |
| 2008 | 22 |
| 2009 | 33 |
| 2010 | 26 |
| 2011 | 43 |
| 2012 | 35 |
| 2013 | 36 |
| 2014 | 34 |
| 2015 | 37 |
| 2016 | 39 |
| 2017 | 29 |
| 2018 | 33 |
| 2019 | 27 |
| 2020 | 25 |
| 2021 | 27 |
| 2022 | 36 |
| 2023 | 37 |
| 2024 | 47 |
| 2025 | 40 |
| 2026 | 36 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 584 |
| Unknown status | 98 |
| Recruiting | 54 |
| Terminated | 32 |
| Not yet recruiting | 28 |
| Active, not recruiting | 21 |
| Withdrawn | 15 |
| Enrolling by invitation | 8 |
| No longer available | 1 |
| Available | 1 |
| Approved for marketing | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 26 |
| Takeda | 21 |
| AstraZeneca | 20 |
| Amgen | 17 |
| Novartis Pharmaceuticals | 13 |
| University Health Network, Toronto | 11 |
| Esperion Therapeutics, Inc. | 9 |
| University of Toronto | 9 |
| Chong Kun Dang Pharmaceutical | 8 |
| Merck Sharp & Dohme LLC | 8 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperlipidemias | 843 |
| Hypertension | 207 |
| Hypercholesterolemia | 139 |
| Diabetes Mellitus | 128 |
| Cardiovascular Diseases | 102 |
| Dyslipidemias | 100 |
| Obesity | 97 |
| Diabetes Mellitus, Type 2 | 53 |
| Metabolic Syndrome | 51 |
| Atherosclerosis | 40 |
Trials
Showing 1 to 25 of 843. Each trial links to its page on Pharma Observatory.
743 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.